Circulating microRNAs associated with gestational diabetes mellitus: useful biomarkers?
Journal of Endocrinology · 01.01.2023 · 256 (1)
DOI: 10.1530/joe-22-0170 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Endocrinology, erschienen am 01.01.2023. Verfasst von Sofie Dinesen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science and Environment, Roskilde University, Universitetsvej 1, Roskilde, Denmark. Hauptthemen laut MEDLINE: Diabetes, Gestational, Circulating MicroRNA, MicroRNAs. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 89 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Different types of small non-coding RNAs, especially miRNAs, may be found in the circulation, either protein-bound or enclosed in extracellular vesicles. During gestation, and particularly during gestational diabetes mellitus (GDM), the levels of several miRNAs are altered. Worldwide the incidence of GDM is increasing, in part driven by the current obesity epidemic. This is a point of public health concern because offspring of women with GDM frequently suffer from short- and long-term complications of maternal GDM. This has prompted the investigation of whether levels of specific miRNA species, detected early in gestation, may be used as diagnostic or prognostic markers for the development of GDM. Here, we summarize the mechanisms of RNA secretion and review circulating miRNAs associated with GDM. Several miRNAs are associated with GDM: miR-29a-3p and miR-29b-3p are generally upregulated in GDM pregnancies, also when measured prior to the development of GDM, while miR-16-5p is consistently upregulated in GDM pregnancies, especially in late gestation. miR-330-3p in circulation is increased in late gestation GDM women, especially in those with poor insulin secretion. miR-17-5p, miR-19a/b-3p, miR-223-3p, miR-155-5p, miR-125-a/b-5p, miR-210-3p and miR-132 are also associated with GDM, but less so and with more contradictory results reported. There could be a publication bias as miRNAs identified early are investigated the most, suggesting that it is likely that additional, more recently detected miRNAs could also be associated with GDM. Thus, circulating miRNAs show potential as biomarkers of GDM diagnosis or prognosis, especially multiple miRNAs containing prediction algorithms show promise, but further studies are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Science and Environment, Roskilde University, Universitetsvej 1, Roskilde, Denmark.
ORCID-Profile: Sofie Dinesen, Alisar El-Faitarouni, Louise T Dalgaard
Zitieren
APA
Dinesen, S., El-Faitarouni, A., & Dalgaard, L. T. (2023). Circulating microRNAs associated with gestational diabetes mellitus: useful biomarkers?. Journal of Endocrinology, 256(1). https://doi.org/10.1530/joe-22-0170
Vancouver
Dinesen S, El-Faitarouni A, Dalgaard LT. Circulating microRNAs associated with gestational diabetes mellitus: useful biomarkers?. Journal of Endocrinology. 2023;256(1). doi:10.1530/joe-22-0170
BibTeX
@article{Dinesen2023,
author = {Dinesen, Sofie and El-Faitarouni, Alisar and Dalgaard, Louise T},
title = {Circulating microRNAs associated with gestational diabetes mellitus: useful biomarkers?},
journal = {Journal of Endocrinology},
year = {2023},
volume = {256},
number = {1},
doi = {10.1530/joe-22-0170}
}
EUVIMED